Related Experiment Video
Updated: Aug 6, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
Atherosclerosis as a risk factor for benign prostatic hyperplasia
Andreas P Berger1, Georg Bartsch, Martina Deibl
1Department of Urology, Medical University of Innsbruck, Austria. andreas.p.berger@uibk.ac.at
Insights
Vascular damage, including diabetes and peripheral arterial occlusive disease, is linked to reduced prostate blood flow and benign prostatic hyperplasia (BPH) symptoms. Impaired blood supply may drive BPH development.
Area of Science:
- Urology
- Vascular Medicine
- Medical Imaging
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Atherosclerosis, a condition affecting blood vessels, is prevalent in aging populations.
- The relationship between systemic vascular health and prostate health requires further investigation.
Purpose of the Study:
- To investigate the association between clinical benign prostatic hyperplasia (BPH) and atherosclerosis.
- To evaluate prostatic vascularity and symptoms in men with varying degrees of vascular disease.
Main Methods:
- Colour Doppler ultrasonography (CDUS) assessed prostatic vascularity in four groups: healthy controls, coronary artery disease (CAD), diabetes mellitus, and peripheral arterial occlusive disease (PAOD).
- Resistive index (RI) and colour pixel density (CPD) quantified prostatic perfusion.
- International Prostate Symptom Score (IPSS) measured lower urinary tract symptoms.
Main Results:
- Diabetic patients and those with PAOD exhibited significantly lower prostatic transition zone (TZ) perfusion (CPD) and higher RI compared to controls and CAD patients.
- Mean prostate volume was larger in diabetic patients and those with PAOD.
- Patients with vascular disease (diabetes, PAOD) reported significantly worse IPSS scores.
Conclusions:
- Reduced prostatic blood flow (lower CPD, higher RI) in patients with vascular disease supports the role of impaired blood supply in BPH development.
- Age-related vascular changes may significantly contribute to the pathogenesis of benign prostatic hyperplasia.
Objectives:
To evaluate the relationship between clinical benign prostatic hyperplasia (BPH) and atherosclerosis, using colour Doppler ultrasonography (CDUS) and symptom scores.
Patients, Subjects And Methods:
CDUS was used to evaluate prostatic vascularity in four groups of men, comprising young healthy subjects, patients presenting with coronary artery disease (CAD), diabetes mellitus, or peripheral arterial occlusive disease (PAOD). Resistive index (RI) measurements and computer-assisted quantification of colour pixel density (CPD) were used to objectively evaluate perfusion. The International Prostate Symptom Score (IPSS) and the International Index of Erectile Function were used to quantify symptoms.
Results:
In diabetic patients and men with PAOD, perfusion of the transition zone (TZ) of the prostate was significantly lower (P < 0.001) and the RI of the TZ was significantly higher (P < 0.001) than in healthy controls and men with CAD. In diabetics and men with PAOD, the mean prostate volume was greater than in healthy controls and men with CAD. The IPSS in patients with vascular damage (diabetes, PAOD) was significantly worse than in the control group.
Conclusions:
The significantly lower CPD and higher RI values of the TZ in patients with vascular disease than in healthy subjects support the hypothesis that an age-related impairment of blood supply to the prostate has a key role in the development of BPH.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...